Results 171 to 180 of about 74,938 (266)

Neurotransmitter signaling in white matter [PDF]

, 2014
Butt, Arthur M., Fern, Robert F., Matute, Carlos   +2 more
core   +1 more source

Purinergic Receptors in Dendritic Cells. [PDF]

J Inflamm Res
Wang M, Zhao X, Hou S, Wu Z, Yin HY.
europepmc   +1 more source

Caffeine in cerebrovascular research: To withdraw or not to withdraw?

Experimental Physiology, Volume 111, Issue 2, Page 335-339, 1 February 2026.
Brooke R. Shepley, Kevin J. Milne, Anthony Richard Bain   +2 more
wiley   +1 more source

Damage response signaling by the extracellular adenosine pathway: control of infection outcome during host aging. [PDF]

mSphere
Bhalla M, Simmons SR, Lenhard A, Betadpur A, Battaglia MC, Bou Ghanem EN.   +5 more
europepmc   +1 more source

Targeting CD73 and correcting adenosinergic signaling in critically ill patients. [PDF]

Front Pharmacol
Lunderberg JM, Spicer AJ, Cassavaugh J, Jalkanen J, Haskó G, Robson SC.   +5 more
europepmc   +1 more source

Dissociation kinetics of G proteins from G protein-coupled receptors and effects of allosteric modulation. [PDF]

Proc Natl Acad Sci U S A
Wang J, Nguyen ATN, Adediwura VA, Lu CS, McNeill SM, Jörg M, Scammells PJ, Christopoulos A, May LT, Miao Y.   +9 more
europepmc   +1 more source

The purinergic signaling interfaces in breast cancer angiogenesis. [PDF]

Purinergic Signal
da Silva FC, Stabile J, Fürstenau CR, Araújo TG.   +3 more
europepmc   +1 more source

Therapeutic potential of adenosine receptor modulators in cancer treatment. [PDF]

RSC Adv
Maity P, Ganguly S, Deb PK.
europepmc   +1 more source

RETRACTED: Zuccarini et al. Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A₁ Receptor Ligands. <i>Cells</i> 2021, <i>10</i>, 3560. [PDF]

Cells
Zuccarini M, Lambertucci C, Carluccio M, Giuliani P, Ronci M, Spinaci A, Volpini R, Ciccarelli R, Di Iorio P.   +8 more
europepmc   +1 more source

The interaction of AB-680, a CD73 inhibitor, with NBTI, a nucleoside transporter inhibitor, on the adenosinergic control of atrial contractility. [PDF]

Front Pharmacol
Ovari I, Brezniczky AB, Laczovics A, Berényi E, Erdei T, Ojo O, Hornok B, Juhasz B, Szilvassy Z, Zsuga J, Viczjan G, Gesztelyi R.   +11 more
europepmc   +1 more source